4//SEC Filing
Gauthier George 4
Accession 0001209191-23-057112
CIK 0001496323other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 7:02 PM ET
Size
7.1 KB
Accession
0001209191-23-057112
Insider Transaction Report
Form 4
Gauthier George
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-11-15$5.02/sh+1,740$8,735→ 40,822 total - Sale
Common Stock
2023-11-29$6.21/sh−1,180$7,331→ 39,642 total
Footnotes (3)
- [F1]The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]This transaction was executed in multiple trades at prices ranging from $5.79 to $6.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001857434
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 7:02 PM ET
- Size
- 7.1 KB